HONG KONG—This city, with its population of 6.7 million, has so far borne the brunt of the severe acute respiratory syndrome (SARS) epidemic. At the beginning of this week, it accounted for 1557 of the world's 5050 cases and 138 of 321 deaths. It has also become a laboratory for the epidemiology, etiology, and treatment of SARS and for the public health response to it. Hong Kong's biomedical researchers have been in the thick of the race to understand and treat the disease. And last weekend researchers from Hong Kong, along with colleagues from mainland China and Taiwan, gathered at a symposium here to review progress and assess future challenges.
No takes yet. Share an insight, caveat, or question.
Dennis Normile (2003) studied this question.